HIV prevention drug could reduce number of cases globally but USAID cuts prevent access, say experts

Experts at the Aids 2026 Conference in Rio de Janeiro stated that injectable PrEP drug lenacapavir holds promise for dramatically reducing global HIV cases. US foreign aid cuts will prevent those most in need from accessing the medication.